Sodium‐glucose cotransporter 2 inhibitor luseogliflozin improves glycaemic control, assessed by continuous glucose monitoring, even on a low‐carbohydrate diet

von Nishimura, R., Omiya, H., Sugio, K., Ubukata, M., Sakai, S., Samukawa, Y.
Veröffentlicht in Diabetes Obes Metab (2016)

Carcinogenicity in mice and rats of heterocyclic amines in cooked foods.

von Ohgaki, H, Hasegawa, H, Kato, T, Suenaga, M, Ubukata, M, Sato, S, Takayama, S, Sugimura, T
Veröffentlicht 1986

Effects of luseogliflozin, a sodium–glucose co‐transporter 2 inhibitor, on 24‐h glucose variability assessed by continuous glucose monitoring in Japanese patients with type 2 diabe...

von Nishimura, R., Osonoi, T., Kanada, S., Jinnouchi, H., Sugio, K., Omiya, H., Ubukata, M., Sakai, S., Samukawa, Y.
Veröffentlicht in Diabetes Obes Metab (2015)